These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 9888456)
1. Prognostic value of cathepsin D in breast cancer. Westley BR; May FE Br J Cancer; 1999 Jan; 79(2):189-90. PubMed ID: 9888456 [No Abstract] [Full Text] [Related]
3. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors. Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius VM; Blomqvist C Br J Cancer; 1999 Apr; 80(1-2):167-74. PubMed ID: 10389993 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of cathepsin D in breast cancer. Stehle G; Wunder A; Hartung G; Sinn H; Heene DL Br J Cancer; 1999 Dec; 81(8):1427-8. PubMed ID: 10604744 [No Abstract] [Full Text] [Related]
5. The immunohistochemical expression of cathepsin D in colorectal cancer. Valentini AM; Pirrelli M; Armentano R; Caruso ML Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673 [TBL] [Abstract][Full Text] [Related]
6. [Significance of cathepsin B and D in physiologic and pathologic processes]. Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558 [TBL] [Abstract][Full Text] [Related]
7. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763 [TBL] [Abstract][Full Text] [Related]
9. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study. Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409 [TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Zhang YG; DU J; Tian XX; Zhong YF; Fang WG Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479 [TBL] [Abstract][Full Text] [Related]
11. [Significance of cathepsin D in breast cancer]. Rochefort H Rev Prat; 1990 Mar; 40(9):837-9. PubMed ID: 2320913 [No Abstract] [Full Text] [Related]
12. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
13. Cathepsin-D expression in breast lesion: an immunohistochemical study. Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643 [TBL] [Abstract][Full Text] [Related]
14. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients. Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401 [TBL] [Abstract][Full Text] [Related]
15. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients. Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis. Scorilas A; Yotis J; Pateras C; Trangas T; Talieri M Clin Cancer Res; 1999 Apr; 5(4):815-21. PubMed ID: 10213217 [TBL] [Abstract][Full Text] [Related]
17. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155 [TBL] [Abstract][Full Text] [Related]
18. Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast. Fernandez-Aguilar S; Noël JC APMIS; 2008 Jan; 116(1):33-40. PubMed ID: 18254778 [TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma. Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of cathepsin D in breast cancer. A long road to the clinic. Rochefort H Eur J Cancer; 1996 Jan; 32A(1):7-8. PubMed ID: 8695245 [No Abstract] [Full Text] [Related] [Next] [New Search]